Literature DB >> 19780893

Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury.

Yuexin Shan1, Baosong Liu, Lijun Li, Ning Chang, Lei Li, Hanbin Wang, Dianshi Wang, Hua Feng, Carol Cheung, Mingxia Liao, Tianyuan Cui, Shuzo Sugita, Qi Wan.   

Abstract

Dysfunction of PTEN-induced kinase-1 (PINK1) is implicated in neurodegeneration. We report here that oxygen-glucose deprivation (OGD), an in vitro insult mimicking ischemic neuron injury, resulted in a significant reduction of PINK1 protein expression in cultured cortical neurons. The decrease of PINK1 expression was blocked by the antagonists of NMDA receptors. We revealed that the overactivation of NR2B-containing NMDA receptors (NR2BRs) was responsible for the OGD-induced PINK1 reduction. The overactivated NR2BRs also inhibited the phosphorylation, but not the protein expression, of the cell survival-promoting kinase Akt after OGD insult, indicating that OGD-induced reduction of PINK1 protein is specific in the injury paradigm. We further showed that enhancing the protein expression of PINK1 antagonized OGD-induced reduction of Akt phosphorylation, suggesting that Akt may be a downstream target of PINK1 in ischemic neuron injury. Importantly, we provided evidence that both NR2BR antagonist and PINK1 over-expression protected against OGD-induced neuronal death. These results suggest that the overactivation of NR2BRs may contribute to ischemic neuron death through suppressing PINK1-dependent survival signaling. Thus, selectively antagonizing NR2BR signal pathway-induced neurotoxicity may be a potential neuroprotection strategy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19780893     DOI: 10.1111/j.1471-4159.2009.06398.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  MicroRNA-26b/PTEN Signaling Pathway Mediates Glycine-Induced Neuroprotection in SAH Injury.

Authors:  Xingping Qin; Farhana Akter; Lingxia Qin; Qiurong Xie; Xinyu Liao; Rui Liu; Xueting Wu; Nina Cheng; Lingmin Shao; Xiaoxing Xiong; Renzhong Liu; Qi Wan; Songlin Wu
Journal:  Neurochem Res       Date:  2019-10-14       Impact factor: 3.996

2.  PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

Authors:  Cristina Guardia-Laguarta; Yuhui Liu; Knut H Lauritzen; Hediye Erdjument-Bromage; Brittany Martin; Theresa C Swayne; Xuejun Jiang; Serge Przedborski
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

3.  PINK1 overexpression protects against C2-ceramide-induced CAD cell death through the PI3K/AKT pathway.

Authors:  Ruth Mélida Sánchez-Mora; Humberto Arboleda; Gonzalo Arboleda
Journal:  J Mol Neurosci       Date:  2012-01-03       Impact factor: 3.444

4.  PINK1 Silencing Modifies Dendritic Spine Dynamics of Mouse Hippocampal Neurons.

Authors:  C J Hernández; C Báez-Becerra; M J Contreras-Zárate; H Arboleda; G Arboleda
Journal:  J Mol Neurosci       Date:  2019-09-05       Impact factor: 3.444

5.  Liver X Receptor Agonist GW3965 Regulates Synaptic Function upon Amyloid Beta Exposure in Hippocampal Neurons.

Authors:  C Báez-Becerra; F Filipello; A Sandoval-Hernández; H Arboleda; G Arboleda
Journal:  Neurotox Res       Date:  2018-01-03       Impact factor: 3.911

6.  Identification of BERP (brain-expressed RING finger protein) as a p53 target gene that modulates seizure susceptibility through interacting with GABA(A) receptors.

Authors:  Carol C Cheung; Caimei Yang; Thorsten Berger; Kathrin Zaugg; Patrick Reilly; Andrew J Elia; Andrew Wakeham; Annick You-Ten; Ning Chang; Lijun Li; Qi Wan; Tak Wah Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

7.  Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A.

Authors:  Ruben K Dagda; Irene Pien; Ruth Wang; Jianhui Zhu; Kent Z Q Wang; Jason Callio; Tania Das Banerjee; Raul Y Dagda; Charleen T Chu
Journal:  J Neurochem       Date:  2013-11-13       Impact factor: 5.372

8.  PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.

Authors:  Yunjong Lee; Daniel A Stevens; Sung-Ung Kang; Haisong Jiang; Yun-Il Lee; Han Seok Ko; Leslie A Scarffe; George E Umanah; Hojin Kang; Sangwoo Ham; Tae-In Kam; Kathleen Allen; Saurav Brahmachari; Jungwoo Wren Kim; Stewart Neifert; Seung Pil Yun; Fabienne C Fiesel; Wolfdieter Springer; Valina L Dawson; Joo-Ho Shin; Ted M Dawson
Journal:  Cell Rep       Date:  2017-01-24       Impact factor: 9.423

9.  Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection.

Authors:  Zhi-Feng Zhang; Juan Chen; Xin Han; Ya Zhang; Hua-Bao Liao; Rui-Xue Lei; Yang Zhuang; Ze-Fen Wang; Zhiqiang Li; Jin-Cao Chen; Wei-Jing Liao; Hai-Bing Zhou; Fang Liu; Qi Wan
Journal:  Br J Pharmacol       Date:  2017-02-27       Impact factor: 8.739

10.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.